[HTML][HTML] Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
G Maroni, MA Bassal, I Krishnan, CW Fhu… - Communications …, 2021 - nature.com
Lung cancer is the leading cause of cancer deaths. Tumor heterogeneity, which hampers
development of targeted therapies, was herein deconvoluted via single cell RNA …
development of targeted therapies, was herein deconvoluted via single cell RNA …
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
G Maroni, MA Bassal, I Krishnan, CW Fhu… - COMMUNICATIONS …, 2021 - arpi.unipi.it
Lung cancer is the leading cause of cancer deaths. Tumor heterogeneity, which hampers
development of targeted therapies, was herein deconvoluted via single cell RNA …
development of targeted therapies, was herein deconvoluted via single cell RNA …
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
G Maroni, MA Bassal, I Krishnan… - Communications …, 2021 - pubmed.ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer deaths. Tumor heterogeneity, which hampers
development of targeted therapies, was herein deconvoluted via single cell RNA …
development of targeted therapies, was herein deconvoluted via single cell RNA …
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer.
G Maroni, MA Bassal, I Krishnan… - Communications …, 2021 - search.ebscohost.com
Lung cancer is the leading cause of cancer deaths. Tumor heterogeneity, which hampers
development of targeted therapies, was herein deconvoluted via single cell RNA …
development of targeted therapies, was herein deconvoluted via single cell RNA …
dentification of a targetable KRAS-mutant epithelial population in non-small cell lung cance
G Maroni, MA Bassal, I Krishnan, CW Fhu… - COMMUNICATIONS …, 2021 - bv.fapesp.br
Lung cancer is the leading cause of cancer deaths. Tumor heterogeneity, which hampers
development of targeted therapies, was herein deconvoluted via single cell RNA …
development of targeted therapies, was herein deconvoluted via single cell RNA …
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
G Maroni, MA Bassal, I Krishnan, CW Fhu, V Savova… - 2021 - agris.fao.org
Maroni, Bassal, Krishnan et al. characterise human non-small cell lung cancer (NSCLC)
carrying Kras-mutations by single-cell RNA sequencing. They identify a tumour-specific …
carrying Kras-mutations by single-cell RNA sequencing. They identify a tumour-specific …
[HTML][HTML] Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
G Maroni, MA Bassal, I Krishnan, CW Fhu… - Communications …, 2021 - ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer deaths. Tumor heterogeneity, which hampers
development of targeted therapies, was herein deconvoluted via single cell RNA …
development of targeted therapies, was herein deconvoluted via single cell RNA …
[PDF][PDF] Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
G Maroni, MA Bassal, I Krishnan, CW Fhu… - Communications …, 2021 - repositorio.usp.br
Lung cancer is the leading cause of cancer deaths. Tumor heterogeneity, which hampers
development of targeted therapies, was herein deconvoluted via single cell RNA …
development of targeted therapies, was herein deconvoluted via single cell RNA …
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer.
G Maroni, MA Bassal, I Krishnan, CW Fhu… - Communications …, 2021 - europepmc.org
Lung cancer is the leading cause of cancer deaths. Tumor heterogeneity, which hampers
development of targeted therapies, was herein deconvoluted via single cell RNA …
development of targeted therapies, was herein deconvoluted via single cell RNA …
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
G Maroni, MA Bassal, I Krishnan, CW Fhu… - Communications …, 2021 - epublications.vu.lt
Abstract [eng] Lung cancer is the leading cause of cancer deaths. Tumor heterogeneity,
which hampers development of targeted therapies, was herein deconvoluted via single cell …
which hampers development of targeted therapies, was herein deconvoluted via single cell …